Tech Insider
peptide therapy
Peptide therapies have taken off since the onset of the pandemic and the rise of weight loss drugs like Ozempic.
Tech Insider
OpenAI CEO Sam Altman also attended the Sun Valley conference.
OpenAI CEO Sam Altman said he got scurvy after working too hard on his first start-up, Loopt.